New Customers Get 10% Off – Use Code: LUX10

GLOW

5.0 Reviews

BPC-157 / TB-500 / GHK-Cu (GLOW)GLOW BlendThree-Peptide Research TriadResearch Peptide Blend

A blend of three peptides—BPC-157, TB-500, and GHK-Cu—studied in preclinical and in-vitro models for their interaction with angiogenesis, cellular-migration, and extracellular-matrix pathways. For laboratory research use only.

All products currently listed on this site are for research purposes only.

Original price was: $99.99.Current price is: $89.99.

2 Day FAST Shipping

99%+ Purity Tests

Ships from USA

USA Lab Tested

We accept :

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

How GLOW Works

The Science, Simplified

Triple-Phase Angiogenesis

The combination of BPC-157 and GHK-Cu significantly upregulates Vascular Endothelial Growth Factor (VEGF), the primary signal for new blood vessel formation. Key insight: In research models, BPC-157 is studied for its role in initiating the vascular “scaffold,” while GHK-Cu is studied for its association with the stabilization of newly formed vessels in cell-culture assays.

Cytoskeletal Actin Regulation

TB-500 (Thymosin Beta-4) works by sequestering G-actin, providing the necessary building blocks for cell migration and tissue organization.

Key insight: In cell-culture models, TB-500 has been studied for its role in G-actin sequestration and cell-migration assays, where its presence is associated with altered migration rates relative to control groups.

Extracellular Matrix (ECM) Remodeling

GHK-Cu acts as a signal for fibroblasts to shift from producing "scar-type" collagen to "functional-type" Type I and III collagen.

Key insight: In research models, this triad is studied for its association with more organized collagen-fiber arrangement in extracellular-matrix assays, relative to disordered fiber compaction.

Anti-Inflammatory Gene Modulation

In research models, the blend is studied for its synergistic association with downregulation of proinflammatory cytokines (such as TNF-α and IL-6) alongside upregulation of antioxidant enzymes.

Key insight: In gene-expression studies, GHK-Cu has been observed to modulate a large number of genes associated with inflammatory and antioxidant signaling pathways.

Research Handling Notes

What research literature describes

These compounds are handled as stable research materials; standard laboratory protocols apply given the combined potency of the constituents.

🧿 Handling & Storage Notes

12%

Store lyophilized at -20°C

mild

5%

Reconstitute with bacteriostatic water

mild

8%

Protect from light exposure

mild

Safety Advantage

Physiological Synergy

Because these peptides act on existing biological pathways rather than forcing a synthetic response, they show a wide margin in toxicology research.

Compound Information

Technical specifications for each component

🔬 Molecular Profile

What Is In GLOW?

BPC-157

15 amino acids, 1,419 Da

TB-500

43 amino acids, 4,963 Da

GHK-Cu

3 amino acids + Cu²⁺, 403 Da

Total peptides

3 distinct compounds

Mechanisms

Complementary pathways

🧊 Storage Requirements

Stability Information

BPC-157 and TB-500 are currently in preclinical research stages, while GHK-Cu is studied in cosmetic-science research and ongoing research studies.

Lyophilized (powder)

-20°C long-term

Reconstituted

2-8°C

use within 7 days

Light protection

Store away from light

📋 Research Status

Where Each Stands

BPC-157 and TB-500 are currently in preclinical research stages, while GHK-Cu is studied in cosmetic-science research and ongoing research studies.

BPC-157 studies

200+ publications

TB-500 studies

170+ publications

GHK-Cu studies

130+ publications

Combination studies

Emerging research

Frequently Asked Questions

Common questions about GLOW

GLOW is a research blend that combines three peptides—GHK-Cu, BPC-157, and TB-500. Each is studied in research models for a distinct molecular pathway: angiogenesis signaling (BPC-157), G-actin sequestration and cell migration (TB-500), and extracellular-matrix and collagen signaling (GHK-Cu).
A standard vial addresses only the angiogenesis pathway. GLOW adds TB-500, studied for its role in cell-migration assays, and GHK-Cu, studied for its association with Type I and III collagen signaling in extracellular-matrix models.
In research models, BPC-157 and TB-500 are studied for a complementary interaction across angiogenesis and cell-migration pathways. Investigators examine this combination in in-vitro and preclinical assays to characterize how the two peptides behave together relative to single-peptide conditions.
This is a research compound only, not approved for human or veterinary use. It is intended exclusively for laboratory research use and is not for consumption or administration to humans or animals.
It is supplied as a lyophilized powder. In a laboratory setting it is typically reconstituted with bacteriostatic water, stored refrigerated, protected from light, and handled per standard lab protocols for research materials.

Sources & References

Peer-reviewed research

Growth Hormone & IGF Research

BPC-157 Upregulates Growth Hormone Receptor Expression

2018

Journal of Investigative Dermatology

Thymosin Beta-4 Accelerates Wound Healing

1999

Malinda KM et al.

For laboratory research use only; not for human or animal use. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All research data and findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.